Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
230 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (2)

Medical Condition

  • Show all (170)
  • Blood Disorders (1)
  • Cancer (101)
    • Brain Cancer (3)
    • Breast Cancer (13)
    • Gastrointestinal (2)
    • Gynecologic Cancer (30)
    • (-) Kidney Cancer (1)
    • Leukemia (9)
    • (-) Liver Cancer (2)
    • Lung Cancer (4)
    • Lymphoma (10)
    • Multiple Myeloma (2)
    • Pancreatic Cancer (2)
    • Prostate Cancer (3)
    • Sarcoma (2)
    • Skin Cancer (1)
    • Solid Tumors (4)
  • COVID-19 (Coronavirus) (1)
  • Diabetes (2)
  • Ear, Nose and Throat (1)
  • Endocrine & Metabolic Disease (1)
  • Gastrointestinal and Digestive Diseases (2)
  • Healthy Volunteers (6)
  • Heart Disease (2)
  • Liver Disease (1)
  • Neurological Disorders (3)
  • Obesity (1)
  • Obstetrics & Gynecology (6)
  • Pediatrics (38)
  • Psychiatric Disorders (1)
  • Surgery (1)
  • Transplant (2)
Displaying 1 - 3 of 3

Liquid biopsy and radiomics for liver cancer surveillance

Condition: Cancer / Liver Cancer
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
This study aims to use new technology involving molecular and imaging tests to help detect liver cancer early in patients. Participants enrolled will participate in it for approximately 5 years. The purpose of this study is to determine if an experimental drug, INT-787, is safe and effective in patients who are hospitalized…
Read More

A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer)

Condition: Cancer / Liver Cancer
Investigator: Elizabeth Verna, MD
Status: Closed
Patients will be asked to participate in this research study because they have been diagnosed with hepatocellular carcinoma (HCC) which is a type of liver cancer. By doing this study, researchers hope to: Find out more about patients that have HCC including their age, race/ethnicity, and other medical conditions they may have…
Read More

FRACTION: Study of Drug Combinations in Patients with Advanced Renal Cell Carcinoma

Condition: Cancer / Kidney Cancer
Investigator: Emerson Lim, MD
Status: Closed
We are doing this study to test a drug called MGD009. MGD009 is like an antibody, which is a protein in your blood that helps get rid of germs in your body. MGD009 is made to attach to cancer cells and to T-cells, which are a part of your immune system. Certain T cells have the ability to kill other cells, including…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science